JP2023086719A5 - - Google Patents
Info
- Publication number
- JP2023086719A5 JP2023086719A5 JP2022197331A JP2022197331A JP2023086719A5 JP 2023086719 A5 JP2023086719 A5 JP 2023086719A5 JP 2022197331 A JP2022197331 A JP 2022197331A JP 2022197331 A JP2022197331 A JP 2022197331A JP 2023086719 A5 JP2023086719 A5 JP 2023086719A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- cdk4
- therapeutic agent
- abemaciclib
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163288179P | 2021-12-10 | 2021-12-10 | |
| US63/288,179 | 2021-12-10 | ||
| US202263321218P | 2022-03-18 | 2022-03-18 | |
| US63/321,218 | 2022-03-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023086719A JP2023086719A (ja) | 2023-06-22 |
| JP2023086719A5 true JP2023086719A5 (https=) | 2025-11-06 |
Family
ID=85157124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022197331A Pending JP2023086719A (ja) | 2021-12-10 | 2022-12-09 | Ｃｄｋ４及び６阻害剤で以前に治療された患者におけるホルモン受容体陽性でヒト上皮成長因子受容体２陰性の進行性又は転移性乳がんの治療のためのフルベストラントとのｃｄｋ４及び６阻害剤の併用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240398832A1 (https=) |
| EP (1) | EP4444315A1 (https=) |
| JP (1) | JP2023086719A (https=) |
| KR (1) | KR20240118134A (https=) |
| AU (1) | AU2022408062B2 (https=) |
| CA (1) | CA3240454A1 (https=) |
| IL (1) | IL313422A (https=) |
| MX (1) | MX2024007015A (https=) |
| TW (1) | TW202342044A (https=) |
| WO (1) | WO2023107525A1 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2251677T3 (es) | 2002-01-22 | 2006-05-01 | Warner-Lambert Company Llc | 2-(piridin-2-ilamino)-pirido(2,3-d)pirimidin-7-onas. |
| ATE412650T1 (de) | 2003-07-11 | 2008-11-15 | Warner Lambert Co | Isethionat salz eines selektiven cdk4 inhibitors |
| BRPI0716880A2 (pt) | 2006-09-08 | 2013-10-15 | Pfizer Prod Inc | Síntese de 2-(piridin-2-ilamino)-pirido[2,3-d]pirimidin-7-onas |
| JO2885B1 (en) | 2008-12-22 | 2015-03-15 | ايلي ليلي اند كومباني | Protein kinase inhibitors |
| AR083797A1 (es) | 2010-11-10 | 2013-03-20 | Novartis Ag | Succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]pirimidin-6-carboxilico, proceso para prepararla, intermediarios de dicha sintesis y proceso de preparacion de los mismos |
| SI2958916T1 (sl) | 2013-02-21 | 2018-11-30 | Pfizer Inc. | Trdne oblike selektivnih zaviralcev CDK4/6 |
| KR20180119570A (ko) * | 2016-03-15 | 2018-11-02 | 메리맥 파마슈티컬즈, 인크. | 항-ErbB3 항체를 포함하는 병용 요법을 이용한 ER+, HER2-, HRG+ 유방암의 치료 |
| CN115624552A (zh) | 2017-05-02 | 2023-01-20 | 伊莱利利公司 | 用于乳腺癌的辅助治疗的内分泌疗法和abemaciclib组合 |
| WO2021030248A1 (en) * | 2019-08-12 | 2021-02-18 | Genentech, Inc. | Treatment of breast cancer using combination therapies comprising an atp competitive akt inhibitor, a cdk4/6 inhibitor, and fulvestrant |
-
2022
- 2022-12-07 CA CA3240454A patent/CA3240454A1/en active Pending
- 2022-12-07 IL IL313422A patent/IL313422A/en unknown
- 2022-12-07 US US18/717,475 patent/US20240398832A1/en active Pending
- 2022-12-07 AU AU2022408062A patent/AU2022408062B2/en active Active
- 2022-12-07 EP EP22851077.2A patent/EP4444315A1/en active Pending
- 2022-12-07 WO PCT/US2022/052071 patent/WO2023107525A1/en not_active Ceased
- 2022-12-07 MX MX2024007015A patent/MX2024007015A/es unknown
- 2022-12-07 KR KR1020247022368A patent/KR20240118134A/ko active Pending
- 2022-12-09 TW TW111147357A patent/TW202342044A/zh unknown
- 2022-12-09 JP JP2022197331A patent/JP2023086719A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022022264A5 (https=) | ||
| Bennink et al. | The use of high-dose estrogens for the treatment of breast cancer | |
| Marshall et al. | Amenorrhoea in anorexia nervosa: assessment and treatment with clomiphene citrate | |
| JP2023174661A5 (https=) | ||
| JP2024133474A5 (https=) | ||
| JPH08510993A (ja) | ホルモン補充方法 | |
| JP2019508476A5 (https=) | ||
| JP2005519893A5 (https=) | ||
| KR100782638B1 (ko) | 에스트로겐 화합물 및 프로게스테론 화합물로 이루어진호르몬 조성물 | |
| JP2023175688A5 (https=) | ||
| JP2024102045A5 (https=) | ||
| JP7376540B2 (ja) | リンパ節陽性の初期ホルモン受容体陽性かつヒト上皮成長因子受容体２陰性乳癌の補助治療のための内分泌療法とアベマシクリブとの組み合わせ | |
| JP2003528919A5 (https=) | ||
| JP2023086719A5 (https=) | ||
| JP2005530791A (ja) | 結合型エストロゲンとトリメゲストンの組み合わせを用いたホルモン補充療法 | |
| JPWO2020112765A5 (https=) | ||
| US6245812B1 (en) | Treatment of hot flashes (flushing) using leucine alone or in combination with other branched chain amino acids | |
| IL313422A (en) | CDK4 and 6 inhibitor in combination with FULVESTRANT for the treatment of advanced or metastatic breast cancer in patients with advanced or metastatic breast cancer before CDK 4 and 4 | |
| JP2004529924A5 (https=) | ||
| CA2472309A1 (en) | Multiple dose aromatase inhibitor for treating infertility | |
| JP2005530790A (ja) | 閉経後の障害を治療するためのトリメゲストンおよびエストロゲン | |
| JPWO2021030248A5 (https=) | ||
| CORMIA et al. | Treatment of pustular psoriasis and pustular bacterid with quinacrine (Atabrine) | |
| RU2025129076A (ru) | Способ лечения раннего рака молочной железы с помощью рибоциклиба в комбинации с ингибитором ароматазы | |
| JPWO2023091553A5 (https=) |